CING (Cingulate) Tariff Resilience Score: 7/10 (As of Jun. 27, 2026)


CING Cingulate Inc CING
33 GF Score
Price $4.94
! 1 Warning Sign
View Full Analysis

What is Cingulate Tariff Resilience Score?

Cingulate CING +4.20% 33 Tariff Resilience Score is 7 as of Jun. 27, 2026. GuruFocus rates CING with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 1,378 Biotechnology companies, Cingulate ranks better than 90.42% on this metric.

Cingulate has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Cingulate has Cingulate Inc has limited exposure to international tariffs due to its focus on the domestic healthcare market. Its supply chain is primarily U.S.-based, reducing vulnerability. However, any future global expansion could introduce tariff risks.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Cingulate might have Highly Resilient.

Cingulate  (NAS:CING) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Cingulate Tariff Resilience Score Related Terms

CING vs TIL, XLO, GOSS: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Cingulate's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cingulate Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cingulate's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Cingulate's Tariff Resilience Score falls into.


CING
33GF Score
Cingulate Inc CING
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Cingulate (CING) has a Tariff Resilience Score of 7 as of Jun. 27, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Cingulate ranks #132 out of 1378 companies in the Biotechnology industry, placing it in the top 9.6%.
Is Cingulate's Tariff Resilience Score too high?
Cingulate's current Tariff Resilience Score is 7. The Biotechnology industry median Tariff Resilience Score is 4.00. Cingulate's value of 7 is 75% above this industry median. Based on the distribution chart, Cingulate ranks #132 out of 1378 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Cingulate has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Cingulate's Tariff Resilience Score compare to TIL and XLO?
According to the Biotechnology industry distribution chart, Cingulate ranks #132 out of 1378 companies for Tariff Resilience Score. This places Cingulate in the top 10% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Cingulate's value of 7 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,378 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cingulate's current Tariff Resilience Score of 7 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cingulate's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cingulate stock overvalued right now?
Cingulate (CING) has a current Tariff Resilience Score of 7. The current Tariff Resilience Score is 7 and 75% above the Biotechnology industry median of 4.00. Cingulate's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Cingulate (CING), the current Tariff Resilience Score is 7 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cingulate Business Description

Address 1901 West 47th Place, Kansas, KS, USA, 66205
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.
33GF Score

Get the complete analysis for CING

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.94
Price